Long non-coding RNA TUG1-mediated down-regulation of KLF4 contributes to metastasis and the epithelial-to-mesenchymal transition of colorectal cancer by miR-153-1

References

• Brody H. Colorectal cancer. Nature. 2015;521(7551):S1. doi:10.1038/521S1a25970450
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244–1260.e1216. doi:10.1053/j.gastro.2014.12.03525575572
   PubMed Web of Science ®Google Scholar
• Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res (Phila). 2016;9(12):887–894. doi:10.1158/1940-6207.CAPR-16-012427679553
   PubMed Web of Science ®Google Scholar
• Stoffel EM, Yurgelun MB. Genetic predisposition to colorectal cancer: implications for treatment and prevention. Semin Oncol. 2016;43(5):536–542. doi:10.1053/j.seminoncol.2016.08.00227899184
   PubMed Web of Science ®Google Scholar
• Spronk I, Korevaar JC, Burgers JS, Albreht T, Schellevis FG. Review of guidance on recurrence risk management for general practitioners in breast cancer, colorectal cancer and melanoma guidelines. Fam Pract. 2017;34(2):154–160. doi:10.1093/fampra/cmw14028207044
   PubMed Web of Science ®Google Scholar
• Binefa G, Rodriguez-Moranta F, Teule A, Medina-Hayas M. Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol. 2014;20(22):6786–6808. doi:10.3748/wjg.v20.i22.678624944469
   PubMed Web of Science ®Google Scholar
• Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298–1307. doi:10.1016/j.cell.2013.02.01223498938
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang T, Zhang Z, et al. Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells. Cancer Sci. 2017;108(5):859–867. doi:10.1111/cas.1320128205334
   PubMed Web of Science ®Google Scholar
• Li TH, Zhang JJ, Liu SX, Chen Y. Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer. Medicine (Baltimore). 2018;97(19):e0575. doi:10.1097/MD.000000000001057529742691
   PubMed Web of Science ®Google Scholar
• Li G, Liu K, Du X. Long non-coding RNA TUG1 promotes proliferation and inhibits apoptosis of osteosarcoma cells by sponging miR-132-3p and upregulating SOX4 expression. Yonsei Med J. 2018;59(2):226–235. doi:10.3349/ymj.2018.59.2.22629436190
   PubMed Web of Science ®Google Scholar
• Li C, Gao Y, Li Y, Ding D. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis. Biochem Biophys Res Commun. 2017;491(2):552–557. doi:10.1016/j.bbrc.2017.03.04228302487
   PubMed Web of Science ®Google Scholar
• Zhai HY, Sui MH, Yu X, et al. Overexpression of long non-coding RNA TUG1 promotes colon cancer progression. Med Sci Monit. 2016;22:3281–3287. doi:10.12659/msm.89707227634385
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao Z, Feng W, et al. Long non-coding RNA TUG1 promotes colorectal cancer metastasis via EMT pathway. Oncotarget. 2016;7(32):51713–51719. doi:10.18632/oncotarget.1056327421138
   PubMedGoogle Scholar
• Zeng HF, Yan S, Wu SF. MicroRNA-153-3p suppress cell proliferation and invasion by targeting SNAI1 in melanoma. Biochem Biophys Res Commun. 2017;487(1):140–145. doi:10.1016/j.bbrc.2017.04.03228400282
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhao J, Yi L, Jiang Y. microRNA-153 targets mTORC2 component rictor to inhibit glioma cells. PLoS One. 2016;11(6):e0156915. doi:10.1371/journal.pone.015691527295037
   PubMed Web of Science ®Google Scholar
• Yuan Y, Du W, Wang Y, et al. Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer. Int J Cancer. 2015;136(6):1333–1340. doi:10.1002/ijc.2910325066607
   PubMed Web of Science ®Google Scholar
• Wang H, Yu Y, Fan S, Luo L. Knockdown of long noncoding RNA TUG1 inhibits the proliferation and cellular invasion of osteosarcoma cells by sponging miR-153. Oncol Res. 2018;26(5):665–673. doi:10.3727/096504017X1490829841250528411362
   PubMed Web of Science ®Google Scholar
• Swamynathan S, Kenchegowda D, Piatigorsky J, Swamynathan S. Regulation of corneal epithelial barrier function by Kruppel-like transcription factor 4. Invest Ophthalmol Vis Sci. 2011;52(3):1762–1769. doi:10.1167/iovs.10-613421051695
   PubMed Web of Science ®Google Scholar
• Nagata T, Shimada Y, Sekine S, et al. KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer. Breast Cancer. 2017;24(2):326–335. doi:10.1007/s12282-016-0708-127300169
   PubMed Web of Science ®Google Scholar
• Zhao L, Han T, Li Y, et al. The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4. FASEB J. 2017;31(3):893–903. doi:10.1096/fj.201600994R27871067
   PubMed Web of Science ®Google Scholar
• Minami K, Taniguchi K, Sugito N, et al. MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells. Oncotarget. 2017;8(20):33064–33077. doi:10.18632/oncotarget.1652428380435
   PubMedGoogle Scholar
• Wei D, Wang L, Yan Y, et al. KLF4 is essential for induction of cellular identity change and acinar-to-ductal reprogramming during early pancreatic carcinogenesis. Cancer Cell. 2016;29(3):324–338. doi:10.1016/j.ccell.2016.02.00526977883
   PubMed Web of Science ®Google Scholar
• Zhai F, Cao C, Zhang L, Zhang J. miR-543 promotes colorectal cancer proliferation and metastasis by targeting KLF4. Oncotarget. 2017;8(35):59246–59256. doi:10.18632/oncotarget.1949528938633
   PubMedGoogle Scholar
• Ma Y, Wu L, Liu X, et al. KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling. Oncol Rep. 2017;38(2):975–984. doi:10.3892/or.2017.573628656310
   PubMed Web of Science ®Google Scholar
• Xu Q, Liu M, Zhang J, et al. Overexpression of KLF4 promotes cell senescence through microRNA-203-survivin-p21 pathway. Oncotarget. 2016;7(37):60290–60302. doi:10.18632/oncotarget.1120027531889
   PubMedGoogle Scholar
• Chen R, Kong P, Zhang F, et al. EZH2-mediated alpha-actin methylation needs lncRNA TUG1, and promotes the cortex cytoskeleton formation in VSMCs. Gene. 2017;616:52–57. doi:10.1016/j.gene.2017.03.02828344045
   PubMed Web of Science ®Google Scholar
• Cao J, Han X, Qi X, Jin X, Li X. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p. Int J Oncol. 2017;51(4):1115–1123. doi:10.3892/ijo.2017.411028902349
   PubMed Web of Science ®Google Scholar
• Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer. 2017;16(1):5. doi:10.1186/s12943-016-0575-628069000
   PubMedGoogle Scholar
• Xu C, Guo Y, Liu H, Chen G, Yan Y, Liu T. TUG1 confers cisplatin resistance in esophageal squamous cell carcinoma by epigenetically suppressing PDCD4 expression via EZH2. Cell Biosci. 2018;8:61. doi:10.1186/s13578-018-0260-030519392
   PubMed Web of Science ®Google Scholar